United States Capitol at night for a federal 7-OH regulatory update

DEA's July 2026 7-OH Notice of Intent: What Has and Has Not Changed

DEA announced on July 1, 2026 that it had filed notices of intent to temporarily place 7-hydroxymitragynine above specified thresholds and three related substances into Schedule I. The notices were scheduled for Federal Register publication on July 6. As of July 14, the temporary scheduling orders are not yet effective.

That timing is important for accurate reporting. The announcement and notices describe intended action. DEA states that the later temporary order will not be issued before 30 days after publication and will take effect when that order is published.

The action uses thresholds, not only product names

The 7-OH notice describes botanical material above a stated dry-weight threshold and certain alternative articles above stated concentration or per-article thresholds. It also discusses plant-derived extracts, concentrates, processed edibles, and pressed pills in the defined circumstances. A separate notice covers mitragynine pseudoindoxyl, MGM-15, and MGM-16.

This is why a simple headline such as all kratom is banned or every MIT product is exempt is inaccurate. The substance identity, product stage, units, processing description, and applicable threshold all matter.

What customers can verify now

  • Whether the federal document is a notice or an effective order.
  • The exact product format and label identity.
  • Whether a report analyzes source material or a finished product.
  • The sample ID, report date, result units, LOD, and LOQ.
  • The current rules for the destination.

How Kratom Paradise is organizing the distinction

Kratom Paradise keeps botanical leaf products, MIT-labeled products, and 7-OH terminology in separate information lanes. The current catalog does not list 7-OH-centered products. MIT product pages explain their selectors and document relationships without making a product-equivalency claim.

The current MIT chewable tablets are made using the 90% MIT-CH source concentrate associated with internal reference 141690. The available report analyzes that concentrate, not the finished tablet. The source report states 7-OH was ND at the stated reporting limit for its submitted sample, but that result is not presented as a finished-tablet assay or legal certification.

Follow the live tracker

The DEA 7-OH Scheduling Tracker shows the status checked date, threshold summary, and links to the official documents. Confirm the date before relying on any earlier report of the federal status.

What happens next

The next federal milestone is publication of any temporary scheduling order after the required notice period. Until that happens, readers should distinguish the announced intent from an effective scheduling date. When an order is published, its exact effective language—not an estimate based on the earliest possible date—will control the tracker update. Product documentation and destination-specific rules will still need their own review.

Compare label terms in 7-OH vs Kratom vs MIT and product formats in the MIT Products Guide.

Official sources and further reading

Published July 14, 2026. This article reports the status of federal documents as of publication and is not legal or medical advice.

Written By : Kratom Paradise Editorial Team

Previous Article
Next Article